ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2413

Inflammation Regulating microRNAs, Mir-146b, Mir-155 and Mir-192-5p Are Altered in Plasma and Synovial Fluid of Oligoarticular Juvenile Idiopathic Arthritis

Beata Derfalvi1,2,3, Sarah Roberts4, Breanna Hargreaves4 and Sarah McAlpine4, 1Pediatrics, Dalhousie University, Halifax, NS, Canada, 2IWK Health Centre, Halifax, NS, Canada, 32nd. Dept. of Pediatrics, Semmelweis University, Budapest, Hungary, 4Dalhousie University, Halifax, NS, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: inflammation and juvenile idiopathic arthritis (JIA), MicroRNA

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Pediatric Rheumatology – Pathogenesis and Genetics - Poster

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: MicroRNAs (miRNAs) modulate gene expression by inhibiting the translation of targeted mRNAs and causing mRNA degradation in a transcript-specific manner. Several miRNAs have been reported to play an important role in inflammation and autoimmune diseases. Our aim was to identify miRNA biomarkers in oligoarticular juvenile idiopathic arthritis (JIA).

Methods: Total RNA was isolated and microarray profiling on 84 inflammatory miRNAs was performed to identify differentially expressed miRNAs on pooled (n=5) healthy plasma, JIA plasma and synovial fluid (SF) by digital droplet PCR (DDPCR) that enables absolute quantification of nucleic acids. Levels of four candidate miRNAs; miR-125b, miR-146b, miR-155 and miRNA-192-5p in plasma and SF were quantified by DDPCR individually in additional 10 healthy controls and 10 age and gender matched oligoarticular JIA patients. All patients satisfied the ILAR classification criteria, were all ANA positive and non- or only NSAID treated at the time of joint injection when also the blood was collected.

Results:  We identified 11 and 13 miRNAs on the microarray analysis that were at least 2-fold increased or decreased in JIA plasma compared to normal plasma, and in JIA SF compared to JIA plasma, respectively. The differential expression of miR-146b, miR-155 and miR-192-5p were confirmed on individual samples. Levels of miR-146b and miR-155 was increased in plasma (p=0.03 and p=0.01 respectively) of JIA patients and miR-146b was enriched even more at the site of the inflamed joints (p=0.02). MiRNA-192-5p expression was reduced in arthritic joints (p=0.003). MiRNA-125b expression did not show any significant difference.

Conclusion: This is the first study to investigate miRNAs by DDPCR in JIA and especially in SF. Similar to what is known in rheumatoid arthritis, miRNA-146b and miRNA-155 may promote an inflammatory process in oligoarticular JIA. Our novel finding is that miRNA192-5p is down-regulated in JIA in the inflamed joint. This may be involved in suppressing proinflammatory signals. Investigation of miRNAs and exploring their potential biological functions could help to understand the pathogenesis of JIA. The inflammation regulating miRNAs may have the potential to serve as biomarkers of disease or novel therapeutic targets.


Disclosure: B. Derfalvi, None; S. Roberts, None; B. Hargreaves, None; S. McAlpine, None.

To cite this abstract in AMA style:

Derfalvi B, Roberts S, Hargreaves B, McAlpine S. Inflammation Regulating microRNAs, Mir-146b, Mir-155 and Mir-192-5p Are Altered in Plasma and Synovial Fluid of Oligoarticular Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/inflammation-regulating-micrornas-mir-146b-mir-155-and-mir-192-5p-are-altered-in-plasma-and-synovial-fluid-of-oligoarticular-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/inflammation-regulating-micrornas-mir-146b-mir-155-and-mir-192-5p-are-altered-in-plasma-and-synovial-fluid-of-oligoarticular-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology